CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

Once the decision to place a VP shunt has been made, valve selection is of vital importance. There are many valve designs available today. As of 1999 there were at least 127 commercially available ...

Based on these clinical findings, I plan to pursue further research to facilitate the practical application of ultrasound treatment for patients with normal pressure hydrocephalus.” Lee Dong ...

Looking for reliable medications to treat 'Hydrocephalus'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

This is her second trip to the hospital run by CURE, an American faith-based organization that specializes in treating children like Manjeri’s son who suffer from hydrocephalus. It’s a ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

The next step in treating Mr. M was to attempt to determine his responsiveness to ventriculoperitoneal (VP) shunting (Fig 2). Although VP shunting is prone to complications and not appropriate for ...

Figure 2: Development and noninvasive treatment of bilateral subdural hygromas following placement of a programmable shunt for idiopathic normal pressure hydrocephalus. Although CSF shunting is a ...

"CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study" was originally created and published by Medical Device Network, a GlobalData owned brand.

The treatment of choice is the implantation of ... Conclusion: Normal pressure hydrocephalus should always enter into the differential diagnosis of patients who present with its characteristic ...